Sukumar Nagendran's Net Worth

$3.56 Million

Estimate Recalculated Nov 1, 2024 05:49AM EST

Who is Sukumar Nagendran?

Sukumar Nagendran has an estimated net worth of $3.56 Million. This is based on reported shares across multiple companies, which include Health Sciences Acquisitions Corp, Taysha Gene Therapies, Inc., Solid Biosciences Inc., and AveXis, Inc..

SEC CIK

Sukumar Nagendran's CIK is 0001665124

Past Insider Trading and Trends

2017 was Sukumar Nagendran's most active year for acquiring shares with 10 total transactions. Sukumar Nagendran's most active month to acquire stocks was the month of May. 2017 was Sukumar Nagendran's most active year for disposing of shares, totalling 37 transactions. Sukumar Nagendran's most active month to dispose stocks was the month of April. 2019 saw Sukumar Nagendran paying a total of $149,999.70 for 42,258 shares, this is the most they've acquired in one year. In 2017 Sukumar Nagendran cashed out on 32,042 shares for a total of $1,403,349.96, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Health Sciences Acquisitions Corp (IMVT) Snapshot price: $34

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Taysha Gene Therapies, Inc. (TSHA) Snapshot price: $2.09

President and Head R&D

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+2,523.28%
863.62K
—
—
897.84K
Jan 2
Form 4
—
0
—
—
0
Dec 14
Form 4
+17.11%
5K
$0.68
$3,400.00
34.23K
May 16
Form 4
—
0
—
—
0
Dec 30
Form 4
—
0
—
—
0
Jun 17
Form 4
+52.01%
10K
$8.01
$80,100.00
29.23K
Feb 2
Form 4
—
0
—
—
0
Jun 17
Form 4
∞
19.23K
—
—
19.23K
Sep 28
Form 4
—
0
—
—
0
Sep 23
Form 3
—
0
—
—
0
No matching records found

Solid Biosciences Inc. (SLDB) Snapshot price: $8.11

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
Dec 13
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Jun 16
Form 4
+1,612.90%
32.26K
$4.65
$149,999.70
34.26K
Jul 25
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Dec 13
Form 4
—
0
—
—
0
Sep 12
Form 3
—
0
—
—
0
No matching records found

AveXis, Inc. No price found

Sr. VP & Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-3.80K
—
—
0
May 15
Form 4
∞
3.8K
—
—
3.8K
Mar 13
Form 4
—
0
$72.33
-$191,741.59
0
Scheduled
Feb 1 - Mar 1
Form 4
—
0
$68.22
-$177,092.34
0
Scheduled
Feb 1
Form 4
—
0
$64.10
-$162,431.36
0
Scheduled
Jan 2
Form 4
—
0
$56.62
-$135,819.55
0
Scheduled
Dec 1
Form 4
—
0
$59.87
-$147,367.41
0
Scheduled
Nov 1
Form 4
—
0
$57.86
-$140,231.21
0
Scheduled
Oct 2
Form 4
—
0
$55.86
-$133,101.32
0
Scheduled
Sep 1
Form 4
—
0
$55.00
-$130,029.55
0
Scheduled
Aug 1
Form 4
—
0
$50.18
-$112,870.92
0
Scheduled
Jul 3
Form 4
—
0
$44.69
-$93,337.33
0
Scheduled
Jun 1
Form 4
—
0
—
—
0
May 10
Form 4
—
0
$49.93
-$111,992.34
0
Scheduled
May 1
Form 4
—
0
$47.30
-$102,692.46
0
Scheduled
Apr 3
Form 4
—
0
—
—
0
Jun 20
Form 3
—
0
—
—
0
No matching records found